SCHEDULE 13G/A: T. Rowe Price Discloses Minor Outset Medical Stake
Beneficial Ownership Report
T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G, reporting beneficial ownership of 2,399 shares, representing 0.0% of Outset Medical Inc.'s common stock.
Summary
- T. Rowe Price Investment Management, Inc. filed an Amendment No. 2 to Schedule 13G regarding Outset Medical Inc.
- The filing reports beneficial ownership of 2,399 shares of Outset Medical Inc. common stock.
- This ownership represents 0.0% of the total class of securities.
- T. Rowe Price Investment Management, Inc. holds sole voting power and sole dispositive power over all 2,399 shares.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine disclosure of a minor institutional ownership stake, with no material impact on company operations or financial performance.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of institutional ownership and does not provide information related to broader industry trends or competitive analysis for Outset Medical Inc.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event requiring the filing of this statement |
| 11/14/2025 | Signature date of the filing |
Keywords
Outset Medical Inc, T. Rowe Price Investment Management, Schedule 13G, common stock, beneficial ownership, institutional ownership, medical devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.